met Apotheken SRL
2.6 FTEmet Apotheken reported total assets of €8.05m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026), with 2.6 full-time equivalents.
The score of met Apotheken shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +437 % Total assets +51 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
met Apotheken's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 09 Jul 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 25 Aug 2023
met Apotheken's financial analysis
- Solvency16.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of met Apotheken
met Apotheken's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0782.370.920
- VAT number
- BE0782370920
- Peppol
- Registered · 0208:0782370920 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Feb 2022
- Registered office
- 3960 Bree
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
met Apotheken (SRL) has been based in Bree since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 399,050 € and equity of €1.29m; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 16.0%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to met Apotheken
Companies in the same business, of comparable size and area, outside its group.
- Torramie Activities of holding companies Evergem · balance sheet €3.79m
- Crobephar Business and other management consultancy activities Quévy · balance sheet €1.56m
- AWM Pharma Activities of holding companies Brussels · balance sheet €1.42m
- DYSS Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet €6.77m
- Chaflo Retail sale of pharmaceutical products Dendermonde · balance sheet €6.17m
- King Kong Retail sale of pharmaceutical products Bertem · balance sheet €4.24m
- VB Farma Retail sale of pharmaceutical products Dentergem · balance sheet €3.67m
- K & K Management Retail sale of pharmaceutical products Mol · balance sheet €2.36m
Frequently asked questions about met Apotheken
What is the revenue of met Apotheken?
met Apotheken files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of met Apotheken?
In Belgium, the VAT number is the company number prefixed with BE: BE0782370920 for met Apotheken, if the company is VAT-registered. Its company number (CBE) is 0782.370.920.
Where is the registered office of met Apotheken?
According to the CBE register, the registered office of met Apotheken is in 3960 Bree.
What is the equity of met Apotheken?
At the close of the 2025 financial year, the equity of met Apotheken amounts to 1,285,793 €, a solvency of 16.0% of total assets.
How many people work at met Apotheken?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages met Apotheken?
The register lists 8 active mandates at met Apotheken. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of met Apotheken
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →